Literature DB >> 25655067

Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study.

Joachim H Ix1, Mary L Biggs2, Kenneth Mukamal3, Luc Djousse4, David Siscovick5, Russell Tracy6, Ronit Katz7, Joseph A Delaney8, Paulo Chaves9, Dena E Rifkin10, Jan M Hughes-Austin11, Pranav S Garimella12, Mark J Sarnak12, Michael G Shlipak13, Jorge R Kizer14.   

Abstract

Tubulointerstitial fibrosis is common with ageing and strongly prognostic for ESRD but is poorly captured by eGFR or urine albumin to creatinine ratio (ACR). Higher urine levels of procollagen type III N-terminal propeptide (PIIINP) mark the severity of tubulointerstitial fibrosis in biopsy studies, but the association of urine PIIINP with CKD progression is unknown. Among community-living persons aged ≥65 years, we measured PIIINP in spot urine specimens from the 1996 to 1997 Cardiovascular Health Study visit among individuals with CKD progression (30% decline in eGFR over 9 years, n=192) or incident ESRD (n=54) during follow-up, and in 958 randomly selected participants. We evaluated associations of urine PIIINP with CKD progression and incident ESRD. Associations of urine PIIINP with cardiovascular disease, heart failure, and death were evaluated as secondary end points. At baseline, mean age (±SD) was 78±5 years, mean eGFR was 63±18 ml/min per 1.73 m(2), and median urine PIIINP was 2.6 (interquartile range, 1.4-4.2) μg/L. In a case-control study (192 participants, 231 controls), each doubling of urine PIIINP associated with 22% higher odds of CKD progression (adjusted odds ratio, 1.22; 95% confidence interval, 1.00 to 1.49). Higher urine PIIINP level was also associated with incident ESRD, but results were not significant in fully adjusted models. In a prospective study among the 958 randomly selected participants, higher urine PIIINP was significantly associated with death, but not with incident cardiovascular disease or heart failure. These data suggest higher urine PIIINP levels associate with CKD progression independently of eGFR and ACR in older individuals.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  cells; fibrosis; geriatric nephrology; progression of chronic renal failure; tubule

Mesh:

Substances:

Year:  2015        PMID: 25655067      PMCID: PMC4587692          DOI: 10.1681/ASN.2014070696

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  37 in total

1.  Analysis of case-cohort designs.

Authors:  W E Barlow; L Ichikawa; D Rosner; S Izumi
Journal:  J Clin Epidemiol       Date:  1999-12       Impact factor: 6.437

2.  Computing the Cox model for case cohort designs.

Authors:  T M Therneau; H Li
Journal:  Lifetime Data Anal       Date:  1999-06       Impact factor: 1.588

3.  Prognostic value of simple measurement of chronic damage in renal biopsy specimens.

Authors:  A J Howie; M A Ferreira; D Adu
Journal:  Nephrol Dial Transplant       Date:  2001-06       Impact factor: 5.992

4.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

5.  Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.

Authors:  K D Bentsen; J H Henriksen; F Bendtsen; K Hørslev-Petersen; I Lorenzen
Journal:  Hepatology       Date:  1990-06       Impact factor: 17.425

Review 6.  Clinical evaluation of kidney function--glomerular function.

Authors:  J P Kassirer
Journal:  N Engl J Med       Date:  1971-08-12       Impact factor: 91.245

7.  Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.

Authors:  J Risteli; S Niemi; P Trivedi; O Mäentausta; A P Mowat; L Risteli
Journal:  Clin Chem       Date:  1988-04       Impact factor: 8.327

8.  Benign nephrosclerosis: incidence, morphology and prognosis.

Authors:  S Takebayashi; Y Kiyoshi; S Hisano; N Uesugi; Y Sasatomi; J Meng; N Sakata
Journal:  Clin Nephrol       Date:  2001-05       Impact factor: 0.975

Review 9.  Tubulointerstitial changes as a major determinant in the progression of renal damage.

Authors:  K A Nath
Journal:  Am J Kidney Dis       Date:  1992-07       Impact factor: 8.860

10.  Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.

Authors:  Anna-Maija Teppo; Tom Törnroth; Eero Honkanen; Carola Grönhagen-Riska
Journal:  Transplantation       Date:  2003-06-27       Impact factor: 4.939

View more
  25 in total

1.  Spot urine sodium measurements do not accurately estimate dietary sodium intake in chronic kidney disease.

Authors:  Carly E Dougher; Dena E Rifkin; Cheryl Am Anderson; Gerard Smits; Martha S Persky; Geoffrey A Block; Joachim H Ix
Journal:  Am J Clin Nutr       Date:  2016-06-29       Impact factor: 7.045

2.  Associations of Urine Biomarkers with Kidney Function Decline in HIV-Infected and Uninfected Men.

Authors:  Simon B Ascher; Rebecca Scherzer; Michelle M Estrella; Michael G Shlipak; Derek K Ng; Frank J Palella; Mallory D Witt; Ken Ho; Michael R Bennett; Chirag R Parikh; Joachim H Ix; Vasantha Jotwani
Journal:  Am J Nephrol       Date:  2019-09-25       Impact factor: 3.754

3.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 4.  Emerging biomarkers of chronic kidney disease in children.

Authors:  Jason H Greenberg; Aadil Kakajiwala; Chirag R Parikh; Susan Furth
Journal:  Pediatr Nephrol       Date:  2017-06-17       Impact factor: 3.714

5.  Association of Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The Cardiovascular Health Study.

Authors:  Dominik Steubl; Petra Buzkova; Pranav S Garimella; Joachim H Ix; Prasad Devarajan; Michael R Bennett; Paolo H M Chaves; Michael G Shlipak; Nisha Bansal; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2019-05-22       Impact factor: 8.860

6.  Association of serum and urinary uromodulin and their correlates in older adults-The Cardiovascular Health Study.

Authors:  Dominik Steubl; Petra Buzkova; Joachim H Ix; Prasad Devarajan; Michael R Bennett; Paolo H M Chaves; Michael G Shlipak; Nisha Bansal; Mark J Sarnak; Pranav S Garimella
Journal:  Nephrology (Carlton)       Date:  2019-12-27       Impact factor: 2.506

Review 7.  Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Authors:  Vasantha Jotwani; Mohamed G Atta; Michelle M Estrella
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

Review 8.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

9.  Urine Anion Gap to Predict Urine Ammonium and Related Outcomes in Kidney Disease.

Authors:  Kalani L Raphael; Sarah Gilligan; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-02       Impact factor: 8.237

10.  Association of Non-Steroidal Anti-Inflammatory Drugs with Kidney Health in Ambulatory Older Adults.

Authors:  Jonathan G Amatruda; Ronit Katz; Carmen A Peralta; Michelle M Estrella; Harini Sarathy; Linda F Fried; Anne B Newman; Chirag R Parikh; Joachim H Ix; Mark J Sarnak; Michael G Shlipak
Journal:  J Am Geriatr Soc       Date:  2020-12-10       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.